Transferrin-receptor shuttles distribute antibody cargo throughout the parenchyma, steering clear of ARIA-provoking vascular amyloid. Trontinemab is enrolling Phase 3 for early AD, announces plans for ...

The field now has more evidence that tightening the tau spigot may slow Alzheimer’s progression. At this year’s Alzheimer’s Association International Conference, held July 12–15 in London, Catherine ...

As more people with Alzheimer’s disease start taking anti-amyloid drugs, research studies will have to adjust. At the Alzheimer’s Association International Conference, held in London July 12-15, ...

Building 114, Suite 2011 16th Street Charlestown, MA02129 United States Visit Website Contact: Bradley T. Hyman, M.D., Ph.D. Phone: (617) 726-3987 E-mail: bhyman@partners.org Brain Banks Home ...

At AAIC, Biogen presented diranersen data. Despite missing its endpoint, the drug showed enough target engagement and cognitive benefit to go to Phase 3.

Lomecel-B is a preparation of multipotent stem and progenitor cells isolated from donated bone marrow of young healthy adults, and expanded in culture. The cells are administered by intravenous ...